Tony Boualoy, Dhiaeddine Djabri, Doug A Gouchoe, Bryan A Whitson, Sylvester M Black
{"title":"Organ Assessment and Repair Centers: Navigating Practical Hurdles in a New Era of Transplantation.","authors":"Tony Boualoy, Dhiaeddine Djabri, Doug A Gouchoe, Bryan A Whitson, Sylvester M Black","doi":"10.1097/TP.0000000000005826","DOIUrl":null,"url":null,"abstract":"<p><p>Solid organ transplantation remains limited by the availability and quality of donor organs. Despite advances in donor management and allocation policy, a substantial proportion of recovered organs are discarded, and increasing reliance on extended-criteria and donation after circulatory death donors introduces additional uncertainty regarding graft viability. Traditional preservation using static cold storage provides a limited opportunity to assess organ function or intervene therapeutically before transplantation. Recent advances in machine perfusion technologies have begun to reshape this paradigm by enabling donor organs to be maintained and evaluated ex vivo. Normothermic perfusion platforms allow real-time physiologic assessment and biochemical monitoring, while hypothermic approaches primarily support preservation with more limited capacity for functional evaluation. These capabilities have created the foundation for the development of organ assessment and repair centers (ARCs), specialized platforms designed to centralize perfusion-based organ evaluation and potential rehabilitation. This overview examines the rationale for regionalized ARC systems and their potential to expand donor organ utilization while improving graft preservation and viability assessment. We discuss the clinical and logistical advantages of centralized perfusion platforms, including mitigation of ischemia/reperfusion injury, improved viability assessment, centralized expertise, integrated research infrastructure, and opportunities for organ-directed therapeutic interventions. We also examine the practical challenges associated with ARC implementation, including financial costs, infrastructure requirements, regulatory oversight, and logistical coordination across transplant networks. As machine perfusion technologies continue to evolve, ARCs may provide the infrastructure needed to integrate advanced preservation, diagnostics, and therapeutic interventions into routine transplant practice, enabling more effective utilization of the donor organ pool.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2007-e2016"},"PeriodicalIF":4.9000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/TP.0000000000005826","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Solid organ transplantation remains limited by the availability and quality of donor organs. Despite advances in donor management and allocation policy, a substantial proportion of recovered organs are discarded, and increasing reliance on extended-criteria and donation after circulatory death donors introduces additional uncertainty regarding graft viability. Traditional preservation using static cold storage provides a limited opportunity to assess organ function or intervene therapeutically before transplantation. Recent advances in machine perfusion technologies have begun to reshape this paradigm by enabling donor organs to be maintained and evaluated ex vivo. Normothermic perfusion platforms allow real-time physiologic assessment and biochemical monitoring, while hypothermic approaches primarily support preservation with more limited capacity for functional evaluation. These capabilities have created the foundation for the development of organ assessment and repair centers (ARCs), specialized platforms designed to centralize perfusion-based organ evaluation and potential rehabilitation. This overview examines the rationale for regionalized ARC systems and their potential to expand donor organ utilization while improving graft preservation and viability assessment. We discuss the clinical and logistical advantages of centralized perfusion platforms, including mitigation of ischemia/reperfusion injury, improved viability assessment, centralized expertise, integrated research infrastructure, and opportunities for organ-directed therapeutic interventions. We also examine the practical challenges associated with ARC implementation, including financial costs, infrastructure requirements, regulatory oversight, and logistical coordination across transplant networks. As machine perfusion technologies continue to evolve, ARCs may provide the infrastructure needed to integrate advanced preservation, diagnostics, and therapeutic interventions into routine transplant practice, enabling more effective utilization of the donor organ pool.
期刊介绍:
The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year.
Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.
Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed.
The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation.